[1]
2026. Reflections on the Scope of Rights Holders in Securities Representative Litigation: — Insights from the Kangmei Pharmaceutical Case. 法学年鉴. 1, 2 (May 2026), 70–75. DOI:https://doi.org/10.63313/Law.8020.